Pakistan vs Philippines: Access to anti-retroviral drugs, female
Pakistan
24.0%
in 2024
Philippines
21.0%
in 2024
Pakistan rank
136th
Philippines rank
138th
Access to anti-retroviral drugs, female over time
- Pakistan
- Philippines
How they compare
Pakistan currently reports 24.0% against 21.0% in Philippines, a difference of 3.0%.
That makes Pakistan's figure about 1.1 times Philippines's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Philippines ahead.
Pakistan ranks 136th and Philippines ranks 138th of 141 countries.
Philippines has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Pakistan | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.4% | 3.5% | 1.1% | Philippines |
| 2010s | 6.9% | 13.2% | 6.3% | Philippines |
| 2020s | 17.8% | 21.0% | 3.2% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Pakistan or Philippines?
- Pakistan, at 24.0% against 21.0% in Philippines as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Pakistan and Philippines?
- 3.0%, with Pakistan ahead.
- How many years of comparable data are there for Pakistan and Philippines?
- 25 years are reported by both, from 2000 to 2024.
- How do Pakistan and Philippines rank globally for access to anti-retroviral drugs, female?
- Pakistan ranks 136th and Philippines ranks 138th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.